CIBC Private Wealth Group
TENX icon

CIBC Private Wealth Group’s Tenax Therapeutics TENX Stock Holding History

CIBC Private Wealth Group’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-343
Closed -$1.09K – 3292
2024
Q2 		$1.09K Hold
343
– – ﹤0.01% 2887
2024
Q1 		$1.31K Buy
+343
New +$2.63K ﹤0.01% 2825
2018
Q1 		– Hold
0
– – – 2065
2017
Q4 		– Hold
0
– – – 1983

Other funds holding TENX

BVF Inc
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vivo Capital
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
VR Adviser
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Velan Capital Investment Management
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vestal Point Capital
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
ADAR1 Capital Management
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Stonepine Capital Management
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Sphera Funds Management
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

CIBC Private Wealth Group's TENX Position: Q3 2024 in Review

CIBC Private Wealth Group sold out of Tenax Therapeutics (TENX) in Q3 2024, closing a stake of 343 shares — an estimated $1.09K sold.

CIBC Private Wealth Group first reported a position in TENX in Q1 2024 and held it in 2 quarters. The position peaked at $1.31K in Q1 2024. 20 funds tracked by Wall St. Rank hold TENX as of Q3 2024.

  • CIBC Private Wealth Group reported no remaining Tenax Therapeutics position as of Q3 2024 after selling out during the quarter.
  • CIBC Private Wealth Group sold 343 Tenax Therapeutics shares in Q3 2024, an estimated $1.09K.
  • CIBC Private Wealth Group first reported a position in Tenax Therapeutics in Q1 2024 and held it in 2 quarters.
  • CIBC Private Wealth Group's Tenax Therapeutics position peaked at $1.31K in Q1 2024.
  • 20 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q3 2024.

Based on CIBC Private Wealth Group's 13F filing for Q3 2024, filed 13 Nov 2024.